This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The University of British Columbia, Other. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 963 
1 out of 834,570 Years Active: 2017-2022
Title: Yuzhuo Wang - Innovator in Cancer Therapeutics
Introduction
Yuzhuo Wang, based in Vancouver, CA, is a distinguished inventor, primarily recognized for his contributions to cancer therapeutics. With a remarkable portfolio of three patents, Wang's work focuses on innovating treatments that target specific biochemical processes in cancer cells.
Latest Patents
Yuzhuo Wang's latest inventions include groundbreaking patents related to monocarboxylate transporter (MCT) antisense oligonucleotide (ASO) inhibitors. These inhibitors are designed for use as therapeutics in the treatment of cancer. The patented compositions and methods aim to modulate MCT4 activity, particularly in cancer cells characterized by elevated expression of MCT4. The cancers targeted by these inventions include, but are not limited to, prostate cancer, renal cell carcinoma, breast cancer, cervical cancer, liver cancer, bladder cancer, and small cell lung cancer. Notably, Wang's research also addresses treatment options for castration-resistant prostate cancer (CRPC), demonstrating the potential of his innovations in providing effective therapies.
Career Highlights
Yuzhuo Wang has been affiliated with the University of British Columbia, where he has conducted significant research within the field of cancer therapeutics. His educational background and research efforts have positioned him as a pivotal figure in the exploration of molecular biology and its applications in medicine.
Collaborations
Throughout his career, Wang has collaborated with various professionals, including notable coworkers such as Stephen Yiu Chuen Choi and Hui Xue. These collaborations have enhanced his research endeavors, contributing to the successful development of his patented inventions.
Conclusion
Yuzhuo Wang's innovative approach to cancer treatment through the development of monocarboxylate transporter inhibitors showcases the impact of dedicated research and collaboration in the medical field. As an inventor with a clear vision for improving cancer therapeutics, Wang continues to inspire future advancements in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile